Differential DNA Methylation in Purified Human Blood Cells: Implications for Cell Lineage and Studies on Disease Susceptibility

Abstract

Methylation of cytosines at CpG sites is a common epigenetic DNA modification that can be measured by a large number of methods, now even in a genome-wide manner for hundreds of thousands of sites. The application of DNA methylation analysis is becoming widely popular in complex disorders, for example, to understand part of the “missing heritability”. The DNA samples most readily available for methylation studies are derived from whole blood. However, blood consists of many functionally and developmentally distinct cell populations in varying proportions. We studied whether such variation might affect the interpretation of methylation studies based on whole blood DNA. We found in healthy male blood donors there is important variation in the methylation profiles of whole blood, mononuclear cells, granulocytes, and cells from seven selected purified lineages. CpG methylation between mononuclear cells and granulocytes differed for 22% of the 8252 probes covering the selected 343 genes implicated in immune-related disorders by genome-wide association studies, and at least one probe was differentially methylated for 85% of the genes, indicating that whole blood methylation results might be unintelligible. For individual genes, even if the overall methylation patterns might appear similar, a few CpG sites in the regulatory regions may have opposite methylation patterns (i.e., hypo/hyper) in the main blood cell types. We conclude that interpretation of whole blood methylation profiles should be performed with great caution and for any differences implicated in a disorder, the differences resulting from varying proportions of white blood cell types should be considered.

DNA methylation array analyses identified breast cancer‐associated HYAL2 methylation in peripheral blood

“…30 Interrogating our Illumina 27K data by the algorithm introduced by Houseman et al, 29 we found significantly higher granulocytes proportion in BC patients than in controls (68.…”

Differential DNA methylation and PM2.5 species in a 450K epigenome-wide association study

“…In the analysis, we controlled for the following covariates a priori based on the relevant literature: 6,19,26,27 total PM 2.5 mass, cell proportions (CD4 C T lymphocytes, CD8 C T lymphocytes, natural killer cells, B cells, monocytes) estimated by the Houseman et al method, [28][29][30] age, body mass index [BMI, computed as weight (in kilograms) divided by height (in square meters)], cigarette pack years, smoking status (never, ever), alcohol consumption ( 2 drinks/day, < 2 drinks/day), years of education, year and season (spring: March-May, summer: June-August, fall: September-November, winter: December-February). Potential batch effects were also considered, including plate, the position of the chip on plate, and the row and column position on the chip.…”

Reprogramming of the human intestinal epigenome by surgical tissue transposition

“…Mucus production and white blood cell count decrease substantially with time, but it remains important to exclude urine samples with substantial contamination in order to measure the correct population of cells in analyzing DNA methylation changes in the neobladder. In our study, we used tissue-specific DNA methylation loci as surrogate markers to confirm the identity of the cell population collected from the neobladder urine sediments (Houseman et al 2012;Reinius et al 2012). We have previously generated Infinium HumanMethylation27 data for normal blood, small intestine, and bladder, from which we identified inflammatory cell-specific probes which are specifically unmethylated in white blood cells and methylated in normal small intestine and urothelium (Supplemental Fig.…”